内分泌指南

订阅

MedSci主页 / 所有栏目 / 内分泌指南

2022更新—2015 NICE指南：成人2型糖尿病的管理（NG.28）

2022-03-31 英国国家卫生与临床优化研究所 NICE官网

糖尿病内分泌科成人2型糖尿病

2022年3月，英国国家卫生与临床优化研究所 (NICE)更新了2015年版成人2型糖尿病的管理指南。指南涵盖了成人2型糖尿病患者的护理和管理。本次更新，专家小组通过回顾最新证据，主

中文标题：

2022更新—2015 NICE指南：成人2型糖尿病的管理（NG.28）

英文标题：

NICE guideline [NG28]：Type 2 diabetes in adults: management

发布机构：

英国国家卫生与临床优化研究所

发布日期：

2022-03-31

简要介绍：

2022年3月，英国国家卫生与临床优化研究所 (NICE)更新了2015年版成人2型糖尿病的管理指南。指南涵盖了成人（≥18岁）2型糖尿病患者的护理和管理。本次更新，专家小组通过回顾最新证据，主要针对连续血糖监测提出了新的指导建议。

点击此处←查看中文译文

相关资料下载：
[AttachmentFileName(sort=1, fileName=2022更新—2015 NICE指南：成人2型糖尿病的管理（NG.28）.pdf)] GetToolGuiderByIdResponse(projectId=1, id=7c9a51c002a012e4, title=2022更新—2015 NICE指南：成人2型糖尿病的管理（NG.28）, enTitle=NICE guideline [NG28]：Type 2 diabetes in adults: management, guiderFrom=NICE官网, authorId=0, author=, summary=2022年3月，英国国家卫生与临床优化研究所 (NICE)更新了2015年版成人2型糖尿病的管理指南。指南涵盖了成人2型糖尿病患者的护理和管理。本次更新，专家小组通过回顾最新证据，主, cover=https://img.medsci.cn/202241/1648805382491_1608702.png, journalId=0, articlesId=null, associationId=2005, associationName=英国国家卫生与临床优化研究所 , associationIntro=英国国家卫生与临床优化研究所 (NICE,National Institute for Health and Clinical Excellence), copyright=0, guiderPublishedTime=Thu Mar 31 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2022年3月，英国国家卫生与临床优化研究所 (NICE)更新了2015年版成人2型糖尿病的管理指南。指南涵盖了成人（&ge;18岁）2型糖尿病患者的护理和管理。本次更新，专家小组通过回顾最新证据，主要针对连续血糖监测提出了新的指导建议。</span></p> <p><strong><span style="color: #373737;"><a href="https://www.medsci.cn/guideline/show_article.do?id=933eb1c002698966" target="_blank" rel="noopener">点击此处</a>&larr;查看中文译文</span></strong></p>, tagList=[TagDto(tagId=216, tagName=糖尿病), TagDto(tagId=17782, tagName=内分泌科), TagDto(tagId=100585, tagName=成人2型糖尿病)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌, tenant=100), CategoryDto(categoryId=8, categoryName=糖尿病, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=216, articleKeyword=糖尿病, articleKeywordNum=6, guiderKeywordId=216, guiderKeyword=糖尿病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5818, appHits=324, showAppHits=0, pcHits=673, showPcHits=5494, likes=2, shares=54, comments=5, approvalStatus=1, publishedTime=Sat Apr 02 15:27:00 CST 2022, publishedTimeString=2022-03-31, pcVisible=1, appVisible=1, editorId=0, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=dajiong, createdTime=Fri Apr 01 17:34:32 CST 2022, updatedBy=6459136, updatedName=艺玮, updatedTime=Fri Jan 05 21:56:37 CST 2024, courseDetails=[], otherVersionGuiders=[OtherVersionToolGuiderDto(projectId=1, id=933eb1c002698966, title=【中文译文】2022更新—2015 NICE指南：成人2型糖尿病的管理（NG.28）, enTitle=NICE guideline [NG28]：Type 2 diabetes in adults: management, guiderPublishedTime=Thu Mar 31 00:00:00 CST 2022, createdTime=Wed Sep 28 16:41:36 CST 2022)], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2022更新—2015 NICE指南：成人2型糖尿病的管理（NG.28）.pdf)])
2022更新—2015 NICE指南：成人2型糖尿病的管理（NG.28）.pdf
下载请点击：
其他版本
【中文译文】2022更新—2015 NICE指南：成人2型糖尿病的管理（NG.28）
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1210760, encodeId=7d361210e608d, content=都英文，看不懂, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d2f5531172, createdName=ms6000001833964428, createdTime=Wed Apr 13 07:23:26 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219042, encodeId=454c121904282, content=学习学习再学习！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu May 12 12:38:49 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214765, encodeId=c1c01214e6562, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 19:59:57 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208960, encodeId=e5d812089605d, content=很好！好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75895311122, createdName=148898f3m13(暂无昵称), createdTime=Wed Apr 06 12:08:48 CST 2022, time=2022-04-06, status=1, ipAttribution=)]
    2022-04-13 ms6000001833964428

    都英文，看不懂

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1210760, encodeId=7d361210e608d, content=都英文，看不懂, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d2f5531172, createdName=ms6000001833964428, createdTime=Wed Apr 13 07:23:26 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219042, encodeId=454c121904282, content=学习学习再学习！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu May 12 12:38:49 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214765, encodeId=c1c01214e6562, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 19:59:57 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208960, encodeId=e5d812089605d, content=很好！好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75895311122, createdName=148898f3m13(暂无昵称), createdTime=Wed Apr 06 12:08:48 CST 2022, time=2022-04-06, status=1, ipAttribution=)]
    2022-05-12 湘雅科教

    学习学习再学习！

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1210760, encodeId=7d361210e608d, content=都英文，看不懂, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d2f5531172, createdName=ms6000001833964428, createdTime=Wed Apr 13 07:23:26 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219042, encodeId=454c121904282, content=学习学习再学习！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu May 12 12:38:49 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214765, encodeId=c1c01214e6562, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 19:59:57 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208960, encodeId=e5d812089605d, content=很好！好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75895311122, createdName=148898f3m13(暂无昵称), createdTime=Wed Apr 06 12:08:48 CST 2022, time=2022-04-06, status=1, ipAttribution=)]
    2022-04-26 su_yi_fei

    很实用

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1210760, encodeId=7d361210e608d, content=都英文，看不懂, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5d2f5531172, createdName=ms6000001833964428, createdTime=Wed Apr 13 07:23:26 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219042, encodeId=454c121904282, content=学习学习再学习！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu May 12 12:38:49 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214765, encodeId=c1c01214e6562, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 19:59:57 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208960, encodeId=e5d812089605d, content=很好！好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75895311122, createdName=148898f3m13(暂无昵称), createdTime=Wed Apr 06 12:08:48 CST 2022, time=2022-04-06, status=1, ipAttribution=)]
    2022-04-06 148898f3m13(暂无昵称)

    很好！好好学习

    0

相关指南

2022更新—2015 NICE指南：成人1型糖尿病的诊断和管理（NG.17）

英国国家卫生与临床优化研究所 (NICE,National Institute for Health and Clinical Excellence) · 2022-03-31

2022更新—2015 NICE指南：儿童和青年人糖尿病（1型和2型）的诊断和管理（NG.18）

英国国家卫生与临床优化研究所 (NICE,National Institute for Health and Clinical Excellence) · 2022-03-31

2型糖尿病患者体重管理专家共识

空军军医大学西京医院内分泌代谢科 · 2022-01-20

2型糖尿病短期胰岛素强化治疗专家共识（2021年版）

《2型糖尿病短期胰岛素强化治疗专家共识》编写委员会 · 2022-01-20

2022 SID/AMD指南：2型糖尿病的治疗

意大利糖尿病学会(SID,Italian Society of Diabetology) · 2022-02-04

2022 JBDS-IP指南：成人糖尿病酮症酸中毒的管理

英国糖尿病协会联合住院治疗组(JBDS-IP,Joint British Diabetes Societiesfor Inpatient Care Group) · 2022-02-27

拓展阅读

BMC Public Health：苏丹北部成年人打鼾与高血压和糖尿病相关

苏丹北部大约四分之一的成年人打鼾。打鼾在肥胖的成年人中更为常见，同时打鼾与高血压和2型糖尿病的发病率增加有关。

MC Cardiovasc Disord：预测急性失代偿慢性心力衰竭和糖尿病患者在重症监护病房48小时后住院死亡率的新模型

本研究构建了一种简单而准确的诺模图来预测ADCHF合并糖尿病患者的住院死亡率，尤其是那些在重症监护病房住院超过48小时的患者，有助于临床医生评估风险并对患者进行个体化治疗，从而降低住院死亡率。

Environ Health Prev Med ：母亲糖尿病和后代先天性心脏病风险的关系

先天性心脏病是新生儿中最常见的先天性疾病。然而，成年重度冠心病患者的生存率明显低于普通人群。

改善糖尿病合并CKD患者结局的综合管理策略（IWGDF 2023）

改善糖尿病合并CKD患者结局的综合管理策略（IWGDF 2023）

Front Cardiovasc Med：RF-CL与CACS-CL模型对稳定型心绞痛合并糖尿病患者冠状动脉阻塞预测概率和预测预后方面的比较

预计到2045年，全球糖尿病（DM）患者人数将增至7亿。全球葡萄糖代谢受损的负担日益加重。

Adv Sci：空军军医大学陈俊/武俊杰发现糖尿病前期神经病理性疼痛新型治疗靶点

该研究旨在探讨PDNP的发生机制并确定潜在的治疗靶点。

2009 中国糖尿病护理及教育指南

中华医学会糖尿病学分会(CDS,Chinese Diabetes Society) · 2009-10-30

2010CARI 2型糖尿病患者的肾功能评估

澳大利亚肾病指南委员会(CARI,Caring for Australasians with Renal Impairment) · 2010-01-01

2010CARI 2型糖尿病患者中慢性肾脏病的预防和管理

澳大利亚肾病指南委员会(CARI,Caring for Australasians with Renal Impairment) · 2010-01-01

2010 AOA（POA）糖尿病患者眼部健康

美国视觉协会(AOA,American Optometric Association) · 2010-01-01

中国糖尿病医学营养治疗指南 （2010年）

中华医学会糖尿病学分会(CDS,Chinese Diabetes Society) · 2010-01-01

运动与2型糖尿病联合声明

美国糖尿病学会(ADA,American Diabetes Association) · 2010-01-01